SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as the company announced volume shipments of its NVIDIA Blackwell Ultra solutions, sparking bullish sentiment among investors. The community is actively discussing potential positive revisions to analyst earnings estimates and a potential rerating of the stock. Some investors express caution related to the company's historical compliance issues, while others highlight the Nokia partnership and Oracle integrations.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending due to a new CEO appointment and the return of founders to the board, sparking a surge in retail investor interest and talk of a potential short squeeze. Community discussions revolve around the new leadership's potential to drive growth and speculation about future price targets, while some traders are eyeing potential pullbacks to add to their positions. The stock's movement is also influenced by broader market factors, including upcoming Federal Reserve decisions and mortgage rate trends.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending due to a recent surge in price and volume, fueled by excitement around its AI-powered visual search technology and anticipation for upcoming earnings. Community members are actively discussing the potential for a short squeeze and the company's undervalued status compared to its peers, with some pointing to a possible stop loss hunt during after hours. The stock's connection to Microsoft and Google is also a key talking point, as investors weigh the potential impact of these partnerships.

A simplified crypto predictions platform Binary token price predictions in a simple Up / Down mechanism.  - No risk of liquidation  - Hedge against volatile markets  - Bi-directional access to tokens that have no perpetual futures listing

Hilo

Hilo is trending as the community anticipates a breakout, citing strong momentum and a potential 'rocket launch' setup. Discussions suggest the market is beginning to recognize Hilo's potential, with many highlighting its growing energy.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to significant price movement and high short interest, sparking discussions of a potential short squeeze within the community. Community members are actively debating the potential for a buyout, citing upcoming presentations and key data points. The stock's focus on treating MASH cirrhosis, a market with few approved therapies, is also contributing to the heightened interest.

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.

Upexi Inc

Upexi Inc is trending as Solana's price increases, with community members discussing the potential impact on UPXI's net asset value and potential gains. Bullish sentiment is fueled by upcoming Solana ETFs and a new Solana treasury company. Some traders are wary of potential share dilution affecting the stock's performance.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's earnings and forward guidance have sparked significant community discussion, with many highlighting the company's success in monetizing AI tools and raising fiscal forecasts. Upgrades from analysts and a focus on Adobe's AI capabilities are key talking points, though some caution against potential overvaluation. The community is actively debating whether Adobe can sustain its growth and fend off competition in the AI space.

BGSF, Inc. engages in providing consulting, managed services, and professional workforce solutions. It operates through the Property Management and Professional segments. The Property Management segment offers office and maintenance talent in 38 states and D.C. to property management companies responsible for the apartment communities’ and commercial buildings’ day-to-day operations. The Professional segment is involved with specialized talent and business consultants for information technology, managed services, finance, accounting, legal and human resource. The company was founded on August 27, 2007, and is headquartered in Plano, TX.

BGSF Inc

$BGSF is trending due to news of a special dividend, with the community drawing comparisons to similar plays like $SOGP and anticipating a multi-day run. Bullish sentiment is fueled by the significant dividend payout relative to the stock price and a relatively small float. Some traders are wary of a potential shakeout by shorts given the company's low float.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is trending amid speculation of a potential acquisition by Paramount Skydance, sending the stock to a multi-year high, with talks of a bidding war emerging. The community is actively discussing potential buyout prices, regulatory hurdles, and how this merger could reshape the streaming landscape, challenging rivals like Netflix. Some traders believe this could be a strategic move by the Ellison family, with potential benefits for Paramount, while others are skeptical of the deal's financial feasibility and impact on shareholders.

Trump For President

The TRUMP.X crypto is trending amidst mixed community sentiment, with discussions ranging from its potential and utility to its correlation with political events and figures. Some traders speculate on upcoming price movements, while others express skepticism about its long-term value. Community members are also discussing the potential impact of wider economic factors and the crypto market on TRUMP.X.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences Announces Completion of Acquisition of CymaBay

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in...

CymaBay Therapeutics (CBAY, $32.48) Aroon Indicator entered an Uptrend on March 21, 2024.

Over the last three days, A.I.dvisor has detected that CBAY's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

CymaBay Therapeutics (CBAY, $32.47) Aroon Indicator entered an Uptrend on March 20, 2024.

CymaBay Therapeutics (CBAY, $32.48) Aroon Indicator entered an Uptrend on March 19, 2024.

CymaBay Therapeutics (CBAY, $32.48) Aroon Indicator entered an Uptrend on March 18, 2024.

CymaBay Therapeutics (NASDAQ:CBAY) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY  Get Free Report) in a research note issued to investors on Sunday. The brokerage set a...

CymaBay Therapeutics (CBAY, $32.45) Aroon Indicator entered an Uptrend on March 15, 2024.

CymaBay Therapeutics (CBAY, $32.47) Aroon Indicator entered an Uptrend on March 14, 2024.

CymaBay Therapeutics (CBAY, $32.44) Aroon Indicator entered an Uptrend on March 13, 2024.

CymaBay Therapeutics (CBAY, $32.45) Aroon Indicator entered an Uptrend on March 12, 2024.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline.  Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenateâ??s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.

CBAY
Cymabay Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CBAY News

CBAY Cymabay Therapeutics Inc